Table 2 Actigraphic activity-sleep characteristics during the wake period and sleep period of non-small cell lung cancer patients compared to population-based controls
| Â | Wake Period | Sleep Period | By Site | |||
|---|---|---|---|---|---|---|
Actigraphic Parameters | All patients | Population controls | All patients | Population controls | Inpatients | Outpatients |
Cases | 68 | 35 | 68 | 35 | 35 | 33 |
Mean activity(accel/min) | 126.9 ± 4.9* | 182.6 ± 25 | ND | ND | 111.7 ± 7.1 | 143.0 ± 5.6 |
Wake minutes | 797.5 ± 26* | 947.1 ± 10.9 | 95.0 ± 8.8* | 31.1 ± 3.6 | 714.2 ± 36 | 885.8 ± 31 |
Sleep minutes | 208.8 ± 18* | 47.1 ± 10.9 | 284.0 ± 18.3* | 417.8 ± 9.4 | 241.3 ± 25 | 174.4 ± 24 |
% Sleep | 20.9 ± 1.8* | 4.7 ± 0.7 | 72.5 ± 2.0* | 93.0 ± 0.8 | 25.8 ± 2.8 | 15.6 ± 1.9 |
Duration of longest sleep (min) | 43.0 ± 2.8* | 23.6 ± 0.6 | 91.7 ± 7.4* | 225.6 ± 17 | 45.4 ± 4.0 | 40.5 ± 3.9 |
Sleep Latency | NA | NA | 20.8 ± 2.5* | 12.1 ± 6.9 | NA | NA |
Sleep Efficiency | NA | NA | 79.8 ± 1.7* | 95.9 ± 0.7 | NA | NA |